Skip to main content
. 2019 Oct 15;19:845. doi: 10.1186/s12879-019-4469-2

Fig. 1.

Fig. 1

The first patient’s PET/MRI at 12-month anti-TB medication therapy (b) revealed the decreased bone marrow edema, pre- and intra-vertebral abscesses, paraspinal soft tissues, and SUVmax (from 9.75 to 1.83) on L2–3 compared with PET/MRI at 4-month anti-TB medication therapy (a). There was no relapse during the one-year follow-up period after discontinuation of treatment